Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
New Atlantic Ventures is an early-stage venture capital firm that invests in high-growth technology companies with a focus on massive scalability. Based in Reston, Virginia, and Cambridge, Massachusetts, the firm targets sectors such as cybersecurity, mobile technology, digital media, and big data, while maintaining a significant presence in the digital health and medical technology space. The firm was established in 2006 as a spin-out from Draper Atlantic and is a member of the Draper Venture Network. Its healthcare-related portfolio includes investments in companies specializing in medical imaging AI, healthcare administration platforms, and patient access solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New Atlantic Ventures.